NCT07747935 — "Study of Neoadjuvant RBP-01 In Patients With Primary Uveal Melanoma" trial site landscape

Public-registry site landscape for NCT07747935, “Study of Neoadjuvant RBP-01 In Patients With Primary Uveal Melanoma”, a Uveal Melanoma study sponsored by ReBio Pharma. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07747935 (registry record)
Study title	Study of Neoadjuvant RBP-01 In Patients With Primary Uveal Melanoma
Official title	A Phase 1b, Open-Label, Investigator-Led Study of Neoadjuvant RBP-01 In Patients With Primary Uveal Melanoma
Sponsor	ReBio Pharma
Condition(s)	Uveal Melanoma
Phase	PHASE1 / PHASE2
Listed sites	0

Patient-friendly overview of this study: eichor.com/study/NCT07747935.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07747935 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →